Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001061848 | SCV001226607 | pathogenic | Neurofibromatosis, type 1 | 2023-11-10 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Gln519Lysfs*7) in the NF1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in NF1 are known to be pathogenic (PMID: 10712197, 23913538). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with clinical features of neurofibromatosis type 1 (PMID: 26740943). ClinVar contains an entry for this variant (Variation ID: 856397). For these reasons, this variant has been classified as Pathogenic. |
Baylor Genetics | RCV003467814 | SCV004190802 | pathogenic | Juvenile myelomonocytic leukemia | 2022-07-15 | criteria provided, single submitter | clinical testing |